Your browser doesn't support javascript.
loading
Single-Cell RNA-Sequencing Atlas Reveals the Tumor Microenvironment of Metastatic High-Grade Serous Ovarian Carcinoma.
Deng, Yingqing; Tan, Yuan; Zhou, Dongmei; Bai, Youhuang; Cao, Ting; Zhong, Caizhou; Huang, Weilai; Ou, Yuhua; Guo, Linlang; Liu, Qianqian; Yin, Deling; Chen, Lipai; Luo, Xiping; Sun, Deqiang; Sheng, Xiujie.
Afiliação
  • Deng Y; Key Laboratory of Biological Targeting Diagnosis, Therapy and Rehabilitation of Guangdong Higher Education Institutes, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
  • Tan Y; Department of Cardiology of The Second Affiliated Hospital, Cardiovascular Key Laboratory of Zhejiang Province, School of Medicine, Zhejiang University, Hangzhou, China.
  • Zhou D; Key Laboratory of Biological Targeting Diagnosis, Therapy and Rehabilitation of Guangdong Higher Education Institutes, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
  • Bai Y; Department of Obstetrics and Gynecology, Center for Reproductive Medicine/Department of Fetal Medicine and Prenatal Diagnosis/BioResource Research Center, Key Laboratory for Major Obstetric Disease of Guangdong Province, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
  • Cao T; Department of Cardiology of The Second Affiliated Hospital, Cardiovascular Key Laboratory of Zhejiang Province, School of Medicine, Zhejiang University, Hangzhou, China.
  • Zhong C; Department of Obstetrics and Gynecology, Center for Reproductive Medicine/Department of Fetal Medicine and Prenatal Diagnosis/BioResource Research Center, Key Laboratory for Major Obstetric Disease of Guangdong Province, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
  • Huang W; Key Laboratory of Biological Targeting Diagnosis, Therapy and Rehabilitation of Guangdong Higher Education Institutes, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
  • Ou Y; Department of Cardiology of The Second Affiliated Hospital, Cardiovascular Key Laboratory of Zhejiang Province, School of Medicine, Zhejiang University, Hangzhou, China.
  • Guo L; School of Life Science and Technology, Tongji University, Shanghai, China.
  • Liu Q; Department of Research and Development, Zhejiang Gaomei Genomics, Hangzhou, China.
  • Yin D; Department of Obstetrics and Gynecology, Guangdong Women and Children Hospital, Guangzhou, China.
  • Chen L; Department of Pathology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • Luo X; Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China.
  • Sun D; Department of Cardiology of The Second Affiliated Hospital, Cardiovascular Key Laboratory of Zhejiang Province, School of Medicine, Zhejiang University, Hangzhou, China.
  • Sheng X; Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China.
Front Immunol ; 13: 923194, 2022.
Article em En | MEDLINE | ID: mdl-35935940
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Cistadenocarcinoma Seroso / Carcinoma Endometrioide Tipo de estudo: Guideline / Prognostic_studies Limite: Female / Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Cistadenocarcinoma Seroso / Carcinoma Endometrioide Tipo de estudo: Guideline / Prognostic_studies Limite: Female / Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China